General Information of the Compound
| Compound ID |
CP0221206
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-Bromo-1H-indazole
Show/Hide
|
||||||||||||||||||
| Synonyms |
1h-indazole, 5-bromo-
2H-Indazole, 5-bromo-
4-Nitrotrityl chloride
465529-55-9
5- Bromoindazole
5-Bromo-1H-indazole, 97%
5-Bromo-2H-indazole
5-Bromoindazole
5-brom-1h-indazol
5-bromanyl-1H-indazole
5-bromo-1 h-indazole
5-bromo-1H-indazole
5-bromo-1hindazole
5-bromo-azaindole
5-bromo-indazole
5-bromoazaindole
53857-57-1
AC1LFXVY
AC1Q1H9U
ACMC-209lal
AMBZ0279
CHEMBL16425
CTK1G9336
DTXSID50354020
HID1020
KSC269G3N
MLS000088501
MolPort-029-084-055
PubChem15628
SCHEMBL5562
STVHMYNPQCLUNJ-UHFFFAOYSA-N
cid_761929
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C7H5BrN2
|
||||||||||||||||||
| Molecular Weight |
197.035
|
||||||||||||||||||
| Canonical SMILES |
Brc1ccc2[nH]ncc2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C7H5BrN2/c8-6-1-2-7-5(3-6)4-9-10-7/h1-4H,(H,9,10)
Show/Hide
|
||||||||||||||||||
| InChIKey |
STVHMYNPQCLUNJ-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
53857-57-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound